Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue as Third-line Vasopressor in Septic Shock
NCT04089072Phase 2Unknown
- Sponsor
- Carilion Clinic
- Start
- Dec 2019
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylene blue in septic shock, sponsored by Carilion Clinic. Status: unknown.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT04089072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04089072.